• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis.

作者信息

Ilerhunmwuwa Nosakhare Paul, Wasifuddin Mustafa, Becerra Henry, Rayapureddy Aditya Keerthi, Wang Jen Chin

机构信息

Department of Internal Medicine, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, United States of America.

Incoming resident, Department of Internal Medicine, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, United States of America.

出版信息

Leuk Res Rep. 2023 Aug 6;20:100383. doi: 10.1016/j.lrr.2023.100383. eCollection 2023.

DOI:10.1016/j.lrr.2023.100383
PMID:37592940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10428056/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d768/10428056/58e21369abd8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d768/10428056/58e21369abd8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d768/10428056/58e21369abd8/gr1.jpg

相似文献

1
Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis.美国非典型慢性髓性白血病患者的特征及生存结果：一项基于监测、流行病学和最终结果（SEER）数据库的分析
Leuk Res Rep. 2023 Aug 6;20:100383. doi: 10.1016/j.lrr.2023.100383. eCollection 2023.
2
Underreporting of myeloid malignancies by United States cancer registries.美国癌症登记处对髓系恶性肿瘤的漏报。
Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):474-81. doi: 10.1158/1055-9965.EPI-11-1087. Epub 2012 Jan 11.
3
Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.老年人群慢性髓单核细胞白血病与骨髓增生异常综合征的治疗和结局比较。
Haematologica. 2013 Apr;98(4):584-90. doi: 10.3324/haematol.2012.062547. Epub 2012 Nov 9.
4
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.美国老年急性髓系白血病患者未接受积极治疗的时间模式和预测因素：基于人群的分析。
Cancer. 2019 Dec 1;125(23):4241-4251. doi: 10.1002/cncr.32439. Epub 2019 Sep 4.
5
Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.慢性髓性白血病患者全因死亡率趋势：监测、流行病学和最终结果数据库分析。
Cancer. 2013 Jul 15;119(14):2620-9. doi: 10.1002/cncr.28106. Epub 2013 Apr 26.
6
Survival for older patients with acute myeloid leukemia: a population-based study.老年急性髓系白血病患者的生存：一项基于人群的研究。
Haematologica. 2012 Dec;97(12):1916-24. doi: 10.3324/haematol.2012.066100. Epub 2012 Jul 6.
7
Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017.1975年至2017年美国所有白血病类型的发病率和生存率的长期趋势。
J Cancer. 2021 Feb 22;12(8):2326-2335. doi: 10.7150/jca.52186. eCollection 2021.
8
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.上皮性卵巢癌治疗相关的髓系白血病：一项流行病学分析。
Gynecol Oncol. 2011 Dec;123(3):456-60. doi: 10.1016/j.ygyno.2011.07.097. Epub 2011 Aug 19.
9
Trends in leukemia incidence and survival in the United States (1973-1998).美国白血病发病率及生存率趋势（1973 - 1998年）
Cancer. 2003 May 1;97(9):2229-35. doi: 10.1002/cncr.11316.
10
Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.2001 - 2013年监测、流行病学和最终结果（SEER）数据库分析：成人非特殊类型急性髓系白血病及伴有复发性基因异常的急性髓系白血病的发病率、生存率和危险因素
Acta Haematol. 2018;139(2):115-127. doi: 10.1159/000486228. Epub 2018 Feb 16.

引用本文的文献

1
Comprehensive analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, clinical features, and survival outcomes based on SEER database insights.非典型慢性髓系白血病（aCML）的综合分析：基于监测、流行病学和最终结果（SEER）数据库见解的流行病学、临床特征及生存结局
Leuk Res Rep. 2025 Feb 17;23:100505. doi: 10.1016/j.lrr.2025.100505. eCollection 2025.
2
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia.miR-15a 靶向慢性髓性白血病中的 HSP90 共伴侣 Morgana。
Sci Rep. 2024 Jul 2;14(1):15089. doi: 10.1038/s41598-024-65404-7.

本文引用的文献

1
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia.世界卫生组织定义的非典型慢性髓性白血病的分子遗传学和治疗管理。
Ann Hematol. 2023 Apr;102(4):777-785. doi: 10.1007/s00277-023-05106-8. Epub 2023 Feb 3.
2
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
3
Atypical Chronic Myeloid Leukemia: Where Are We Now?
非典型慢性髓性白血病：我们现在在哪里？
Int J Mol Sci. 2020 Sep 18;21(18):6862. doi: 10.3390/ijms21186862.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database.BCR/ABL阴性慢性髓性白血病的特征与生存情况：基于监测、流行病学及最终结果数据库的回顾性分析
Ther Adv Hematol. 2015 Dec;6(6):308-12. doi: 10.1177/2040620715607416.
6
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.慢性中性粒细胞白血病和非典型 CML 的新遗传学：对诊断和治疗的影响。
Blood. 2013 Sep 5;122(10):1707-11. doi: 10.1182/blood-2013-05-500959. Epub 2013 Jul 29.
7
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.致癌性 CSF3R 突变在慢性中性粒细胞白血病和非典型 CML 中的作用。
N Engl J Med. 2013 May 9;368(19):1781-90. doi: 10.1056/NEJMoa1214514.
8
Identification of risk factors in atypical chronic myeloid leukemia.非典型慢性髓性白血病危险因素的鉴定
Haematologica. 2006 Nov;91(11):1566-8. Epub 2006 Oct 17.
9
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.异基因移植：骨髓纤维化、慢性粒单核细胞白血病及费城染色体阴性/BCR-ABL阴性慢性粒细胞白血病的一种治疗选择。
Bone Marrow Transplant. 2004 May;33(10):1005-9. doi: 10.1038/sj.bmt.1704472.
10
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta.甲磺酸伊马替尼对涉及血小板衍生生长因子受体β的非典型慢性髓性白血病有积极的临床反应。
Blood. 2003 Oct 1;102(7):2699-700. doi: 10.1182/blood-2003-05-1579.